Cingulate Inc. Registration Statement Declared Effective by SEC
Ticker: CING · Form: EFFECT · Filed: Mar 25, 2026 · CIK: 0001862150
Complexity: simple
Sentiment: neutral
Topics: regulatory-approval, capital-raise, securities-offering
TL;DR
**Cingulate's offering is officially effective, clearing the way for them to raise capital.**
AI Summary
The SEC has declared Cingulate Inc.'s registration statement effective as of March 24, 2026. This means the company can now proceed with the offering described in the filing, likely allowing them to raise capital. For investors, this is a green light for Cingulate to execute its financing plans, which could impact future share dilution or provide funds for drug development, making it important for assessing the company's financial runway.
Why It Matters
This filing signals that Cingulate Inc. has met regulatory requirements to proceed with a securities offering, which could provide crucial funding for its operations or drug development pipeline.
Risk Assessment
Risk Level: low — This filing is a procedural update indicating regulatory approval, not a change in the company's financial health or operational risks.
Analyst Insight
Investors should review the underlying registration statement (File No. 333-292680) to understand the specifics of the offering (e.g., type of securities, potential dilution) now that it's effective, as this will impact future share value and company financing.
Key Players & Entities
- Cingulate Inc. (company) — the filer of the EFFECT notice
- SEC (company) — the regulatory body declaring the filing effective
- March 24, 2026 (date) — the effectiveness date of the filing
- 0001862150 (person) — Cingulate Inc.'s CIK number
- 333-292680 (person) — the File No. for the registration statement
FAQ
What is the purpose of an EFFECT filing for Cingulate Inc.?
An EFFECT filing, like this one for Cingulate Inc., indicates that the SEC has declared a previously filed registration statement effective. This means the company has met the necessary regulatory requirements and can now proceed with the offering of securities described in that registration statement, allowing them to raise capital.
When was Cingulate Inc.'s registration statement declared effective?
Cingulate Inc.'s registration statement was declared effective on March 24, 2026, as stated in the filing under 'Effectiveness Date'.
What is Cingulate Inc.'s CIK number and business address?
Cingulate Inc.'s CIK number is 0001862150, and its business address is 1901 W. 47TH PLACE, KANSAS CITY KS 66205, according to the filing.
What type of industry does Cingulate Inc. operate in, based on its SIC code?
Based on its SIC code 2834, Cingulate Inc. operates in the 'Pharmaceutical Preparations' industry, as indicated in the filing.
What is the File No. associated with this EFFECT filing?
The File No. associated with this EFFECT filing is 333-292680, as specified in the filing details.
Filing Stats: 32 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2026-03-25 00:15:14
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-000923.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 24, 2026 4:30 P.M. Form: S-3 CIK: Company Name: Cingulate Inc. File Number: 333-292680